OACCW

MKT CAP:$22M

Oaktree Acquisition Corp. III Life Sciences

Market Cap

$22M

Financial Services·Shell Companies·🇺🇸 United States·NASDAQ

Financials·Shell Companies·🇺🇸·NASDAQ

Stock Price

$0.89-$0.06 (-6.84%)

Apr 17, 2026

Company Details

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more...

CEO

Mathew Pendo

IPO Date

Oct 6, 2025

Website

www.oaktreeacquisitioncorp.com/oac-iii

Key Metrics TTM

Revenue

$0

— YoY

Net Income

$5M

EPS (Diluted)

$0.20

Free Cash Flow

-$146.2K

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

4.7x

Earnings Reports

Q3 2025

Nov 13, 2025

$0EPS $0.08

Q1 2025

May 14, 2025

$0EPS $0.07

FY 2024

Mar 27, 2025

$0EPS $0.05

Q4 2024

Mar 27, 2025

$0EPS $0.06

Q3 2024

Sep 29, 2024

$0EPS -$0.00

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 24	$0	$0	-$48.1K
Q4 24	$0	$0	-$303.7K
Q1 25	$0	$0	$0
Q3 25	$0	$0	-$225.6K

Valuation

Quarter	P/S	P/E
Q3 24	—	—
Q4 24	—	—
Q1 25	—	—
Q3 25	—	3.6x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 24	-$89.7K	-$89.7K
Q3 25	-$56.5K	-$56.5K

Capital Expenditures

Quarter	CapEx
Q4 24	$3
Q3 25	$3

CapEx

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 24	$0	—
Q3 25	$0	—

OpEx Breakdown

Quarter	G&A	SG&A
Q3 24	—	$48.1K
Q4 24	—	$303.7K
Q3 25	$225.6K	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 24	$1M	$0	$1M
Q1 25	$1M	$0	$1M
Q2 25	$1M	$0	$1M
Q3 25	$1M	$0	$1M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 24	22M	—	—
Q4 24	25M	+9.6%	—
Q1 25	19M	-21.9%	—
Q3 25	19M	+0.0%	—

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 24	—	—
Q4 24	$0	1K
Q1 25	$0	1K
Q3 25	$0	1K

Revenue / Employee